U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156526) titled 'Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life' on Aug. 12.
Brief Summary: This randomized, double-blind parallel pilot study will evaluate the safety and efficacy of two Qualia Iron formulations versus placebo in approximately 40 healthy adults (aged 18+) over a 56-day period. Approximately 40 participants will be randomized to three study arms: Qualia Iron Version 1, 2, (n=15 each) or a Placebo (n=10). Each participant will take one or two capsules once daily in the morning, with or without food. The supplementation regimen is a 5 days on, 2 days off protocol, and goes for 56 days (8 weeks). The primary out...